Login to Your Account

EMA opens process on new phase I trial rules, post Bial study death

By Cormac Sheridan
Staff Writer

Tuesday, November 15, 2016

DUBLIN – The EMA launched a formal consultation process Tuesday on the development of a new guideline for first-in-human and early stage clinical trials of investigational drugs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription